CAS 652129-89-0

2-[(4H-1,3-Benzodioxin-6-ylimino)methyl]-4,6-dichlorophenol

Fórmula: C₁₅H₁₁Cl₂NO₃

InChI: InChI=1S/C15H11Cl2NO3/c16-11-3-9(15(19)13(17)5-11)6-18-12-1-2-14-10(4-12)7-20-8-21-14/h1-6,19H,7-8H2

Chave InChI: VDRJYIIXTNQGDZ-UHFFFAOYSA-N

SMILES: C1C2=C(C=CC(=C2)N=CC3=C(C(=CC(=C3)Cl)Cl)O)OCO1

Sinónimos:

• 2-[(4H-1,3-Benzodioxin-6-ylimino)methyl]-4,6-dichlorophenol

BTB01303

CAS: 652129-89-0

BTB01303 is a glutamate release inhibitor that targets the high levels of glutamate released by cancer cells, which disrupts normal bone turnover and can lead to cancer-induced bone pain. BTB01303 has the potential to improve cancer-induced bone pain [1].

Fórmula: C₁₅H₁₁Cl₂NO₃

Cor e Forma: Solid

Peso molecular: 324.16

Ref: TM-T85920